دورية أكاديمية

Eosinophilic oesophagitis: clinical presentation and pathogenesis.

التفاصيل البيبلوغرافية
العنوان: Eosinophilic oesophagitis: clinical presentation and pathogenesis.
المؤلفون: Bystrom J; Bone and Joint Research Unit, William Harvey Research Institute, Barts & the London, Queen Mary University of London, , London, UK., O'Shea NR
المصدر: Postgraduate medical journal [Postgrad Med J] 2014 May; Vol. 90 (1063), pp. 282-9. Date of Electronic Publication: 2014 Mar 19.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0234135 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0756 (Electronic) Linking ISSN: 00325473 NLM ISO Abbreviation: Postgrad Med J Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : Oxford : Oxford University Press
Original Publication: London, Blackwell.
مواضيع طبية MeSH: Adrenal Cortex Hormones/*administration & dosage , Anti-Inflammatory Agents/*administration & dosage , Eosinophilic Esophagitis/*diagnosis , Esophagus/*pathology, Adult ; Constriction, Pathologic/diagnosis ; Constriction, Pathologic/therapy ; Deglutition Disorders/etiology ; Dilatation/methods ; Eosinophilic Esophagitis/complications ; Eosinophilic Esophagitis/pathology ; Eosinophilic Esophagitis/physiopathology ; Eosinophilic Esophagitis/therapy ; Female ; Genetic Predisposition to Disease ; Humans ; Male ; Treatment Outcome
مستخلص: Eosinophilic oesophagitis (EoE) is an inflammatory disorder of the oesophagus which has become increasingly recognised over recent years, although it remains underdiagnosed in many centres. It is characterised histologically by a significant eosinophilic infiltration of the oesophageal mucosa (>15 eosinophils per high powered field), and clinically with features of oesophageal dysfunction such a dysphagia, food impaction, and proton pump inhibitor (PPI) resistant dyspepsia. Fibrosis and oesophageal remodelling may occur and lead to oesophageal strictures. An allergic predisposition is common in the EoE population, which appears to be primarily food antigen driven in children and aeroallergen driven in adults. Evidence suggests that the pathogenesis of EoE is due to a dysregulated immunological response to an environmental allergen, resulting in a T helper type 2 (Th2) inflammatory disease and remodelling of the oesophagus in genetically susceptible individuals. Allergen elimination and anti-inflammatory therapy with corticosteroids are currently the mainstay of treatment; however, an increasing number of studies are now focused on targeting different stages in the disease pathogenesis. A greater understanding of the underlying mechanisms resulting in EoE will allow us to improve the therapeutic options available.
References: Am J Gastroenterol. 2008 Sep;103(9):2184-93. (PMID: 18844613)
J Gastroenterol. 2013 Jan;48(1):81-5. (PMID: 22618806)
Gastrointest Endosc. 2005 Jun;61(7):795-801. (PMID: 15933677)
Postgrad Med J. 2014 May;90(1063):273-81. (PMID: 24664254)
Clin Gastroenterol Hepatol. 2012 Sep;10(9):988-96.e5. (PMID: 22610003)
Clin Gastroenterol Hepatol. 2011 Feb;9(2):110-7. (PMID: 20920599)
Nat Med. 2012 Mar 25;18(4):538-46. (PMID: 22447074)
J Leukoc Biol. 2007 Apr;81(4):916-24. (PMID: 17194734)
J Immunol. 2007 Jul 15;179(2):1080-7. (PMID: 17617600)
J Clin Invest. 2001 Jan;107(1):83-90. (PMID: 11134183)
Gastroenterology. 2012 Jun;142(7):1451-9.e1; quiz e14-5. (PMID: 22391333)
J Allergy Clin Immunol. 2001 Oct;108(4):594-601. (PMID: 11590387)
Gastrointest Endosc. 2007 Feb;65(2):330-4. (PMID: 17258999)
Drugs. 2011 Mar 26;71(5):527-40. (PMID: 21443279)
J Allergy Clin Immunol. 2012 Feb;129(2):456-63, 463.e1-3. (PMID: 22206777)
Gastroenterology. 2008 May;134(5):1316-21. (PMID: 18471509)
Gastroenterology. 1996 Nov;111(5):1200-5. (PMID: 8898633)
Allergy. 2012 Apr;67(4):477-90. (PMID: 22313241)
J Innate Immun. 2011;3(6):594-604. (PMID: 21921589)
J Allergy Clin Immunol. 2006 Dec;118(6):1312-9. (PMID: 17157662)
Gastroenterology. 1978 Jun;74(6):1298-1301. (PMID: 648822)
Ann Allergy Asthma Immunol. 2010 Jun;104(6):496-502. (PMID: 20568382)
Clin Exp Allergy. 1999 Sep;29(9):1172-86. (PMID: 10469025)
Aliment Pharmacol Ther. 2008 Nov 1;28(9):1140-6. (PMID: 18624788)
Aliment Pharmacol Ther. 2010 Feb 15;31(4):509-15. (PMID: 19925501)
Eur J Pediatr. 2011 Nov;170(11):1471-4. (PMID: 21809010)
J Allergy Clin Immunol. 2007 Feb;119(2):509-11. (PMID: 17291865)
J Pediatr Gastroenterol Nutr. 2006 May;42(5):506-9. (PMID: 16707971)
J Allergy Clin Immunol. 2003 Oct;112(4):796-7. (PMID: 14564365)
Anat Rec. 1998 Nov;252(3):418-25. (PMID: 9811220)
Clin Gastroenterol Hepatol. 2005 Dec;3(12):1198-206. (PMID: 16361045)
Gastroenterology. 2003 Dec;125(6):1660-9. (PMID: 14724818)
Gastroenterology. 2007 Oct;133(4):1342-63. (PMID: 17919504)
N Engl J Med. 2011 Sep 22;365(12):1088-98. (PMID: 21812663)
J Pediatr Gastroenterol Nutr. 2011 Aug;53(2):145-9. (PMID: 21788754)
Am J Gastroenterol. 2012 Feb;107(2):215-21. (PMID: 21971538)
Dig Dis Sci. 2011 Jan;56(1):97-102. (PMID: 20458625)
Clin Gastroenterol Hepatol. 2008 May;6(5):598-600. (PMID: 18407800)
J Allergy Clin Immunol. 2011 Jul;128(1):3-20.e6; quiz 21-2. (PMID: 21477849)
Gut. 2013 Apr;62(4):489-95. (PMID: 22619364)
J Allergy Clin Immunol. 2007 Dec;120(6):1292-300. (PMID: 18073124)
Nat Genet. 2010 Apr;42(4):289-91. (PMID: 20208534)
Dig Dis Sci. 1993 Jan;38(1):109-16. (PMID: 8420741)
Gastroenterology. 2011 Nov;141(5):1593-604. (PMID: 21835135)
Gut. 2010 Jan;59(1):21-30. (PMID: 19828470)
PLoS One. 2012;7(11):e50037. (PMID: 23185525)
Allergy. 2013 Mar;68(3):375-85. (PMID: 23379537)
J Allergy Clin Immunol. 2001 Dec;108(6):954-61. (PMID: 11742273)
Curr Gastroenterol Rep. 2009 Jun;11(3):220-5. (PMID: 19463222)
J Allergy Clin Immunol. 2011 Dec;128(6):1349-1350.e5. (PMID: 22019091)
Cell Mol Life Sci. 2007 May;64(10):1269-89. (PMID: 17364144)
Inflammation. 2007 Oct;30(5):153-60. (PMID: 17587163)
J Allergy Clin Immunol. 2010 Jul;126(1):140-9. (PMID: 20538331)
J Allergy Clin Immunol. 2011 Jan;127(1):208-17, 217.e1-7. (PMID: 21211656)
Inflamm Allergy Drug Targets. 2012 Feb;11(1):20-35. (PMID: 22309081)
Am J Gastroenterol. 2012 Oct;107(10):1503-11. (PMID: 22777338)
Immunol Cell Biol. 2013 Jul;91(6):408-15. (PMID: 23689305)
J Clin Gastroenterol. 2007 Mar;41(3):252-6. (PMID: 17426462)
J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):67-71. (PMID: 23518485)
Am J Gastroenterol. 2010 Feb;105(2):298-307. (PMID: 19888203)
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1149-53. (PMID: 17683993)
Gastroenterology. 2003 Nov;125(5):1419-27. (PMID: 14598258)
Clin Gastroenterol Hepatol. 2009 Oct;7(10):1055-61. (PMID: 19577011)
J Allergy Clin Immunol. 2010 Dec;126(6):1198-204.e4. (PMID: 21047675)
Gastroenterology. 2011 Nov;141(5):1586-92. (PMID: 21762663)
J Pediatr Gastroenterol Nutr. 2007 Jan;44(1):20-6. (PMID: 17204948)
J Pharmacol Exp Ther. 2009 Oct;331(1):255-64. (PMID: 19628634)
J Allergy Clin Immunol. 2002 Feb;109(2):363-8. (PMID: 11842310)
Dis Esophagus. 2009;22(3):249-55. (PMID: 19207551)
Gut. 2010 Jan;59(1):12-20. (PMID: 19528036)
Respir Res. 2011 Jan 14;12:10. (PMID: 21235798)
J Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S118-27. (PMID: 14657842)
Clin Gastroenterol Hepatol. 2008 May;6(5):531-5. (PMID: 18304887)
Nat Immunol. 2001 Apr;2(4):353-60. (PMID: 11276207)
J Allergy Clin Immunol. 2007 Jan;119(1):206-12. (PMID: 17208603)
Am J Gastroenterol. 2007 Dec;102(12):2627-32. (PMID: 17764492)
فهرسة مساهمة: Keywords: HISTOPATHOLOGY; IMMUNOLOGY; PUBLIC HEALTH
المشرفين على المادة: 0 (Adrenal Cortex Hormones)
0 (Anti-Inflammatory Agents)
تواريخ الأحداث: Date Created: 20140321 Date Completed: 20150119 Latest Revision: 20211021
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC4495666
DOI: 10.1136/postgradmedj-2012-131403
PMID: 24647582
قاعدة البيانات: MEDLINE
الوصف
تدمد:1469-0756
DOI:10.1136/postgradmedj-2012-131403